Integrating PrEP Decision Making Into Contraceptive Counseling in Family Planning Clinics
Launched by YALE UNIVERSITY · Nov 8, 2024
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how to better incorporate discussions about HIV prevention, specifically Pre-Exposure Prophylaxis (PrEP), into the conversations that happen during contraceptive counseling at family planning clinics. The goal is to ensure that women visiting these clinics not only receive information about birth control but also learn about ways to protect themselves from HIV.
To be eligible for this study, participants need to be cisgender women aged 18 or older, have a uterus, and must not be living with HIV or currently taking PrEP. They should also be comfortable speaking either English or Spanish and able to understand the study details. If you join the study, you can expect to participate in conversations about both contraception and HIV prevention in a supportive environment. It's important to note that women who are trying to get pregnant or who have had certain surgical procedures that prevent pregnancy will not be able to participate.
Gender
FEMALE
Eligibility criteria
- Patients (inclusion):
- • Cis-women
- • Aged 18 years or older
- • Have a uterus
- • Do not have HIV (by self-report)
- • Not currently on PrEP
- • Comfortable conversing in English or Spanish
- • Able to participate in informed consent procedures
- Patients (exclusion):
- • People who cannot become pregnant (i.e., have had a hysterectomy or tubal ligation)
- • People who wish to become pregnant (will not qualify for contraceptive counseling)
- • Have a scheduled visit with a member of the investigative team (to minimize risk of potential ascertainment bias)
- • Participants of Aim 1 cannot participate in Aim 2.
- • Sexual and Reproductive Health (SRH) clinicians will be included if they provide SRH patient care at any of the participating sites. SRH clinic staff will be included if they work at any of the participating sites and have patient-facing or non-patient-facing roles
About Yale University
Yale University, a prestigious Ivy League institution located in New Haven, Connecticut, is renowned for its commitment to advancing medical research and clinical innovation. With a rich history of academic excellence and a robust infrastructure for scientific inquiry, Yale serves as a leading sponsor for clinical trials aimed at improving patient care and developing new therapeutic approaches. The university's multidisciplinary teams of researchers and clinicians collaborate to conduct rigorous and ethical studies, leveraging cutting-edge technologies and methodologies to address critical health challenges. Through its dedication to fostering an environment of inquiry and discovery, Yale University plays a pivotal role in translating research findings into clinical practice, ultimately enhancing health outcomes for diverse populations.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
New Haven, Connecticut, United States
Patients applied
Trial Officials
Jaimie P Meyer, MD
Principal Investigator
Yale Clinical and Community Research, Yale School of Medicine
Sangini S Sheth, MD
Principal Investigator
Obstetrics, Gynecology & Reproductive Sciences, Yale School of Medicine
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported